Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

Abstract The M4 muscarinic acetylcholine receptor (M4 mAChR) has emerged as a drug target of high therapeutic interest due to its expression in regions of the brain involved in the regulation of psychosis, cognition, and addiction. The mAChR agonist, xanomeline, has provided significant improvement...

Full description

Bibliographic Details
Main Authors: Wessel A. C. Burger, Vi Pham, Ziva Vuckovic, Alexander S. Powers, Jesse I. Mobbs, Yianni Laloudakis, Alisa Glukhova, Denise Wootten, Andrew B. Tobin, Patrick M. Sexton, Steven M. Paul, Christian C. Felder, Radostin Danev, Ron O. Dror, Arthur Christopoulos, Celine Valant, David M. Thal
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-41199-5
_version_ 1797558454929326080
author Wessel A. C. Burger
Vi Pham
Ziva Vuckovic
Alexander S. Powers
Jesse I. Mobbs
Yianni Laloudakis
Alisa Glukhova
Denise Wootten
Andrew B. Tobin
Patrick M. Sexton
Steven M. Paul
Christian C. Felder
Radostin Danev
Ron O. Dror
Arthur Christopoulos
Celine Valant
David M. Thal
author_facet Wessel A. C. Burger
Vi Pham
Ziva Vuckovic
Alexander S. Powers
Jesse I. Mobbs
Yianni Laloudakis
Alisa Glukhova
Denise Wootten
Andrew B. Tobin
Patrick M. Sexton
Steven M. Paul
Christian C. Felder
Radostin Danev
Ron O. Dror
Arthur Christopoulos
Celine Valant
David M. Thal
author_sort Wessel A. C. Burger
collection DOAJ
description Abstract The M4 muscarinic acetylcholine receptor (M4 mAChR) has emerged as a drug target of high therapeutic interest due to its expression in regions of the brain involved in the regulation of psychosis, cognition, and addiction. The mAChR agonist, xanomeline, has provided significant improvement in the Positive and Negative Symptom Scale (PANSS) scores in a Phase II clinical trial for the treatment of patients suffering from schizophrenia. Here we report the active state cryo-EM structure of xanomeline bound to the human M4 mAChR in complex with the heterotrimeric Gi1 transducer protein. Unexpectedly, two molecules of xanomeline were found to concomitantly bind to the monomeric M4 mAChR, with one molecule bound in the orthosteric (acetylcholine-binding) site and a second molecule in an extracellular vestibular allosteric site. Molecular dynamic simulations supports the structural findings, and pharmacological validation confirmed that xanomeline acts as a dual orthosteric and allosteric ligand at the human M4 mAChR. These findings provide a basis for further understanding xanomeline’s complex pharmacology and highlight the myriad of ways through which clinically relevant ligands can bind to and regulate GPCRs.
first_indexed 2024-03-10T17:31:39Z
format Article
id doaj.art-7484d1906038449ebf83ab0a1980953a
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:31:39Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-7484d1906038449ebf83ab0a1980953a2023-11-20T10:00:04ZengNature PortfolioNature Communications2041-17232023-09-0114111110.1038/s41467-023-41199-5Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChRWessel A. C. Burger0Vi Pham1Ziva Vuckovic2Alexander S. Powers3Jesse I. Mobbs4Yianni Laloudakis5Alisa Glukhova6Denise Wootten7Andrew B. Tobin8Patrick M. Sexton9Steven M. Paul10Christian C. Felder11Radostin Danev12Ron O. Dror13Arthur Christopoulos14Celine Valant15David M. Thal16Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDepartment of Chemistry, Stanford UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDepartment of Chemistry, Stanford UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityThe Advanced Research Centre (ARC), Centre for Translational Science, School of Biomolecular Sciences, College of Medical, Veterinary and Life Sciences, University of GlasgowDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityKaruna TherapeuticsKaruna TherapeuticsGraduate School of Medicine, University of TokyoDepartments of Computer Science, Structural Biology, and Molecular and Cellular Physiology, Stanford UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash UniversityAbstract The M4 muscarinic acetylcholine receptor (M4 mAChR) has emerged as a drug target of high therapeutic interest due to its expression in regions of the brain involved in the regulation of psychosis, cognition, and addiction. The mAChR agonist, xanomeline, has provided significant improvement in the Positive and Negative Symptom Scale (PANSS) scores in a Phase II clinical trial for the treatment of patients suffering from schizophrenia. Here we report the active state cryo-EM structure of xanomeline bound to the human M4 mAChR in complex with the heterotrimeric Gi1 transducer protein. Unexpectedly, two molecules of xanomeline were found to concomitantly bind to the monomeric M4 mAChR, with one molecule bound in the orthosteric (acetylcholine-binding) site and a second molecule in an extracellular vestibular allosteric site. Molecular dynamic simulations supports the structural findings, and pharmacological validation confirmed that xanomeline acts as a dual orthosteric and allosteric ligand at the human M4 mAChR. These findings provide a basis for further understanding xanomeline’s complex pharmacology and highlight the myriad of ways through which clinically relevant ligands can bind to and regulate GPCRs.https://doi.org/10.1038/s41467-023-41199-5
spellingShingle Wessel A. C. Burger
Vi Pham
Ziva Vuckovic
Alexander S. Powers
Jesse I. Mobbs
Yianni Laloudakis
Alisa Glukhova
Denise Wootten
Andrew B. Tobin
Patrick M. Sexton
Steven M. Paul
Christian C. Felder
Radostin Danev
Ron O. Dror
Arthur Christopoulos
Celine Valant
David M. Thal
Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
Nature Communications
title Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
title_full Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
title_fullStr Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
title_full_unstemmed Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
title_short Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR
title_sort xanomeline displays concomitant orthosteric and allosteric binding modes at the m4 machr
url https://doi.org/10.1038/s41467-023-41199-5
work_keys_str_mv AT wesselacburger xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT vipham xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT zivavuckovic xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT alexanderspowers xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT jesseimobbs xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT yiannilaloudakis xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT alisaglukhova xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT denisewootten xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT andrewbtobin xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT patrickmsexton xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT stevenmpaul xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT christiancfelder xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT radostindanev xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT ronodror xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT arthurchristopoulos xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT celinevalant xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr
AT davidmthal xanomelinedisplaysconcomitantorthostericandallostericbindingmodesatthem4machr